Madeleine covers PCR, nucleic acid amplification, and sample prep technologies for GenomeWeb.
As an expert in zoonotic viruses, Poon has published an assay for SARS-CoV-2 as well as a characterization of early infection.
Leadership aims to lower cost of goods and real estate footprint, while driving test utilization by targeting clinicians.
The plan piggybacks on national influenza surveillance, testing flu-negative samples using the CDC's rRT-PCR test for the novel coronavirus.
A recent study established high sensitivity and specificity for three CLIA waived point-of-care molecular flu tests in pediatric samples.
A handful of rapid 2019-nCoV assays are in the works which could help triage patients more effectively and avoid unnecessary quarantines.
The Centers for Disease Control and Prevention says one of the test reagents will likely need to be remanufactured in its labs.
The agency is also hosting a portal for submissions and inquiries as part of the newly created Medical Countermeasures Taskforce.
A number of firms internationally have announced development of molecular assays and reagents for the novel coronavirus 2019-nCoV.
If granted, emergency use authorization is anticipated to help roll out standardized, consistent 2019-nCoV testing to public health labs in the US.
The system showed good performance for cervical samples as well as orophyrengeal samples, and required no extraction step.